News Search Results
Nov 20, 2025, 12:11 ET SpayVac for Wildlife Inc. Appoints Experienced Global Leader Tina Lloren, MPH, as Director of Operations
MADISON, Wis., Nov. 20, 2025 /PRNewswire/ -- SpayVac for Wildlife Inc., a biotechnology company pioneering single-dose immunocontraceptive vaccines for humane animal population control, today announced the appointment of Tina Lloren,
More news about: SpayVac
Nov 20, 2025, 11:33 ET VIPC Signs MOU with AstraZeneca, Eli Lilly, Merck to Develop the Virginia Center for Advanced Pharmaceutical Manufacturing to Train Workforce of the Future
demonstrates – the power of collaboration to drive transformative growth in our life sciences ecosystem," said John Newby, CEO of the Virginia Biotechnology Association. "Virginia is building a model that connects innovation, education, and industry like never before. This initiative will strengthen
More news about: VIPC
Nov 20, 2025, 10:12 ET PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting
IRVINE, Calif., Nov. 20, 2025 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotechnology company developing novel therapies for relapsed and refractory (r/r) B-cell malignancies, announced that two abstracts from its ongoing Phase 1
More news about: PeproMene Bio, Inc.
Nov 20, 2025, 10:12 ET PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting
IRVINE, Calif., Nov. 20, 2025 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotechnology company developing novel therapies for relapsed and refractory (r/r) B-cell malignancies, announced that two abstracts from its ongoing Phase 1
More news about: PeproMene Bio, Inc.
Nov 20, 2025, 10:04 ET Cannformatics and Dr. Laszlo Mechtler Announce Intent to Launch Lab Service for Personalized Medical Cannabis in Migraine and Other Conditions
SAN FRANCISCO, Nov. 20, 2025 /PRNewswire/ -- Cannformatics, a biotechnology company pioneering Cannabis-Responsive™ biomarker technology, and Dr. Laszlo Mechtler, Chief Medical Officer of the DENT Neurologic Institute the
More news about: Cannformatics
Nov 20, 2025, 10:01 ET Genomics Market worth $85.09 billion by 2030 with 12.6% CAGR | MarketsandMarkets™
Beckman Coulter, which operates under the Life Sciences and Diagnostics segments. The company provides products & services to pharmaceutical and biotechnology companies, colleges & universities, research institutes, and government bodies (including government testing & diagnostic centers) through
More news about: MarketsandMarkets
Nov 20, 2025, 09:43 ET ViVac Appoints Keren Leshem as Chief Executive Officer, Strengthening Leadership to Advance RNA-Lipid Nanoparticle Immunotherapy Platform
cancers. About ViVac Pharma Ltd. ViVac is an early-stage biotechnology company pioneering synthetic biology and lipid nanoparticle engineering to develop RNA-based immunotherapies that safely eradicate cancer
More news about: ViVac Pharma Ltd.
Nov 20, 2025, 09:00 ET ReviR Therapeutics Receives $4.6 Million CIRM Grant to Advance Huntington's Disease Treatment and Announces Key Development Milestone
patients." About ReviR Therapeutics ReviR Therapeutics is a global biotechnology company committed to discovering and developing innovative therapies for patients with serious neurogenetic diseases worldwide. ReviR was founded
More news about: ReviR Therapeutics
Nov 20, 2025, 08:00 ET Young Innovations and Umayana Partner to Launch Murnia® Mouth Spray: Natural Moisture for Persistent Oral Dryness and Daily Oral Health Maintenance
Revolutionary Biotechnology-Based Formula with Patented Molecular Compound Delivers Lasting Comfort Through Natural, Moisture-Rich Ingredients and Multi-Mechanism Support ALGONQUIN,
More news about: Young Innovations
Nov 20, 2025, 08:00 ET Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors
/PRNewswire/ -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced the appointment of biotechnology veteran Christopher Martin to its Board of Directors. Mr. Martin brings proven success across all key commercial functions, including marketing,
More news about: Edgewise Therapeutics
Nov 20, 2025, 07:02 ET Aspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy Programs
SAN DIEGO, Nov. 20, 2025 /PRNewswire/ -- Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, today announced the closing of a $115 million Series C financing round. This significant investment
More news about: Aspen Neuroscience, Inc.
Nov 20, 2025, 07:00 ET SciNeuro Pharmaceuticals to Accelerate Novel LRRK2 Therapeutic (SNP614) Development with an Award from The Michael J. Fox Foundation
About SciNeuro Pharmaceuticals SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio
More news about: SciNeuro Pharmaceuticals
Nov 20, 2025, 06:30 ET Flagship Pioneering Announces New Agreements with ProFound Therapeutics and Quotient Therapeutics Under its Collaboration with GSK
Sana Biotechnology,
More news about: Flagship Pioneering
Nov 20, 2025, 03:55 ET Aerogel Market Expected to Reach USD 6.08 Billion by 2035, Growing at a CAGR of 15.5% | Vantage Market Research
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Nov 20, 2025, 03:26 ET RoboMarkets expands trading opportunities with over 1,300 additional US stocks and ETFs
Enlight Renewable Energy Ltd. (ENLT.nq), Eos Energy Enterprises Inc. (EOSE.nq) Healthcare & Biotechnology: Valneva SE (VALN.nq), Electromed Inc. (ELMD.ny) Diversified & Income Funds: AllianzGI
More news about: RoboMarkets
Nov 20, 2025, 03:26 ET RoboMarkets expands trading opportunities with over 1,300 additional US stocks and ETFs
Enlight Renewable Energy Ltd. (ENLT.nq), Eos Energy Enterprises Inc. (EOSE.nq) Healthcare & Biotechnology: Valneva SE (VALN.nq), Electromed Inc. (ELMD.ny) Diversified & Income Funds: AllianzGI
More news about: RoboMarkets
Nov 20, 2025, 02:55 ET BPC Instruments secures new order for several BPC Go units from a international energy group
instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing
More news about: BPC Instruments AB
Nov 19, 2025, 16:01 ET FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Nov 19, 2025, 13:30 ET King Abdullah International Medical Research Center and Flagship Pioneering Announce Strategic Partnership to Expand Clinical Research of Novel Medicines in Saudi Arabia
KAIMRC, and KSAU-HS, we aim to attract premier clinical research that will not only elevate our healthcare capabilities but also propel our national biotechnology strategy forward. This collaboration represents our unwavering commitment to fostering a vibrant research environment, driving impactful healthcare
More news about: Flagship Pioneering
Nov 19, 2025, 12:20 ET NABR: CITES Standing Committee Issues Assessment of Long-Tailed Macaque Monkey Breeding Practices
research, education, and testing. Members include more than 340 universities, medical and veterinary schools, teaching hospitals, pharmaceutical and biotechnology companies, patient groups, and academic and professional societies who rely on humane and responsible animal research to advance global human and
More news about: National Association for Biomedical Research
Nov 19, 2025, 12:05 ET Elizabeth Gardon Joins Rubin Rudman's Litigation Group
Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin Rudman
Nov 19, 2025, 11:33 ET NABR: CITES Standing Committee Issues Assessment of Long-Tailed Macaque Monkey Breeding Practices
research, education, and testing. Members include more than 340 universities, medical and veterinary schools, teaching hospitals, pharmaceutical and biotechnology companies, patient groups, and academic and professional societies who rely on humane and responsible animal research to advance global human and
More news about: National Association for Biomedical Research
Nov 19, 2025, 11:08 ET Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PROC)
DALLAS, Nov. 19, 2025 /PRNewswire/ -- Dialectic Therapeutics, Inc., a clinical-stage biotechnology company developing innovative anti-cancer drugs, today announced that patient dosing is underway in a clinical trial led by the renowned Drs. Elizabeth
More news about: Dialectic Therapeutics, Inc.
Nov 19, 2025, 10:20 ET Amy Rudolph, PhD, Joins Thryv Therapeutics' Board of Directors to Support Portfolio Progression into Heart Failure
MONTREAL, Nov. 19, 2025 /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, cardiometabolic
More news about: Thryv Therapeutics Inc.
Nov 19, 2025, 10:16 ET Compounding Chemotherapy Market to Reach $6.3 Billion by 2027 in the short run and $9.8 Billion by 2034 Globally, at 6.4% CAGR: Allied Market Research
market, primarily due to increasing cancer cases and rising awareness of personalized treatments. An article published by the National Center for Biotechnology Information (NCBI) in 2023 estimated that the incidence of cancer cases is expected to rise by 12.8% in 2025 compared to 2020. Drivers include a
More news about: Allied Market Research